Robarts Research Institute, University of Western Ontario, London, ON, Canada.
Cell Death Dis. 2013 Mar 14;4(3):e538. doi: 10.1038/cddis.2013.59.
Neuroinflammation is a common feature of acute neurological conditions such as stroke and spinal cord injury, as well as neurodegenerative conditions such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. Previous studies have demonstrated that acute neuroinflammation can adversely affect the survival of neural precursor cells (NPCs) and thereby limit the capacity for regeneration and repair. However, the mechanisms by which neuroinflammatory processes induce NPC death remain unclear. Microglia are key mediators of neuroinflammation and when activated to induce a pro-inflammatory state produce a number of factors that could affect NPC survival. Importantly, in the present study we demonstrate that tumor necrosis factor α (TNFα) produced by lipopolysaccharide-activated microglia is necessary and sufficient to trigger apoptosis in mouse NPCs in vitro. Furthermore, we demonstrate that microglia-derived TNFα induces NPC apoptosis via a mitochondrial pathway regulated by the Bcl-2 family protein Bax. BH3-only proteins are known to play a key role in regulating Bax activation and we demonstrate that microglia-derived TNFα induces the expression of the BH3-only family member Puma in NPCs via an NF-κB-dependent mechanism. Specifically, we show that NF-κB is activated in NPCs treated with conditioned media from activated microglia and that Puma induction and NPC apoptosis is blocked by the NF-κB inhibitor BAY-117082. Importantly, we have determined that NPC apoptosis induced by activated microglia-derived TNFα is attenuated in Puma-deficient NPCs, indicating that Puma induction is required for NPC death. Consistent with this, we demonstrate that Puma-deficient NPCs exhibit an ∼13-fold increase in survival as compared with wild-type NPCs following transplantation into the inflammatory environment of the injured spinal cord in vivo. In summary, we have identified a key signaling pathway that regulates neuroinflammation induced apoptosis in NPCs in vitro and in vivo that could be targeted to promote regeneration and repair in diverse neurological conditions.
神经炎症是急性神经疾病(如中风和脊髓损伤)和神经退行性疾病(如帕金森病、阿尔茨海默病和肌萎缩侧索硬化症)的共同特征。先前的研究表明,急性神经炎症会对神经前体细胞(NPC)的存活产生不利影响,从而限制了再生和修复的能力。然而,神经炎症过程诱导 NPC 死亡的机制尚不清楚。小胶质细胞是神经炎症的关键介质,当被激活诱导炎症状态时,会产生许多可能影响 NPC 存活的因素。重要的是,在本研究中,我们证明脂多糖激活的小胶质细胞产生的肿瘤坏死因子 α(TNFα)足以在体外触发小鼠 NPC 的凋亡。此外,我们证明小胶质细胞衍生的 TNFα 通过 Bax 调节的 Bcl-2 家族蛋白介导的线粒体途径诱导 NPC 凋亡。BH3 仅蛋白已知在调节 Bax 激活中起关键作用,我们证明小胶质细胞衍生的 TNFα 通过 NF-κB 依赖性机制诱导 NPC 中 BH3 仅家族成员 Puma 的表达。具体来说,我们表明 NF-κB 在接受激活的小胶质细胞条件培养基处理的 NPC 中被激活,并且 NF-κB 抑制剂 BAY-117082 阻断了 Puma 诱导和 NPC 凋亡。重要的是,我们确定在缺乏 Puma 的 NPC 中,由激活的小胶质细胞衍生的 TNFα 诱导的 NPC 凋亡被减弱,表明 Puma 诱导是 NPC 死亡所必需的。与此一致,我们证明与野生型 NPC 相比,在体内移植到损伤脊髓的炎症环境中后,缺乏 Puma 的 NPC 的存活增加了约 13 倍。总之,我们已经确定了一个关键的信号通路,该通路调节 NPC 体外和体内的神经炎症诱导的凋亡,该通路可以作为靶向治疗以促进多种神经疾病中的再生和修复。